CLINICAL_TRIALS
trial_result
· 2019-11-18
Clinical Trial Update: The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas [NA]
Summary
Feasibility study of the iLet bihormonal bionic pancreas for type 1 diabetes was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Diabetes Mellitus Type 1 | NA | Status: TERMINATED | Results posted: 2019-11-18